Fundraising FoxCerberus Ventures — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Ansa provides an enzymatic DNA synthesis platform that directly synthesizes complex sequences up to 900 bp and delivers constructs up to 50 kb without assembly-based methods.
BiotechDeep TechHealthtechEmeryville, US
Dan Lin-Arlow(Founder)inSebastian Palluk(Founder)inDaniel Hillel Lin-Arlow(Executive Officer, Director)Jason T. Gammack(Executive Officer, Director)inDaniel Lin-Arlow(Founder)Jared Ellefson(Founder)
Co-investorsCarbon SiliconDauntless VenturesFifty YearsJude GomilaMetaplanetY Combinator+14 more
Nudge is an onchain platform that pays users rewards for reallocating their crypto tokens across categories such as L1s, L2s, stablecoins, and restaking.
Crypto & Web3Richmond, US
Chris Garson(Executive Officer)Phil Beene(Executive Officer, Director)Mac Gambill(Executive Officer, Director)Steven Feyrer-Melk(Executive Officer)
BoardBrian Clare(Director)Tom Blue(Director)
Co-investorsWintermuteAntler
Red Queen Bio builds an AI-powered biodefense system that rapidly designs and manufactures countermeasures against emerging biological threats, enabling faster defensive responses to evolving pathogenic risks.
AI & Machine LearningBiotechDefense Tech
Hannu Rajaniemi(Founder)inNikolai Eroshenko(Founder)in
Co-investorsCompoundLongeVCOK ComputerThe Venture CollectiveFifty YearsHalcyon Futures Investments+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.